世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

不妊治療薬市場:世界の産業動向、シェア、サイズ、成長、機会、2023-2028年予測


Infertility Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

世界の不妊治療薬の市場規模は、2022年に38億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に5.24%の成長率(CAGR)を示し、2028年までに52億米ドルに達すると予測しています。 不妊治療薬... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
IMARC Services Private Limited.
アイマークサービス
2023年3月18日 US$2,499
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
145 英語

 

サマリー

世界の不妊治療薬の市場規模は、2022年に38億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に5.24%の成長率(CAGR)を示し、2028年までに52億米ドルに達すると予測しています。

不妊治療薬とは、不妊症の治療や生殖機能を高めるために使用される様々な薬剤のことを指します。不妊治療薬は、注射や経口投与で使用されます。一般的に使用される不妊治療薬には、ゴナドトロフィン、アロマターゼ阻害剤、選択的エストロゲン受容体モジュレーター(SERM)、ビグアナイド、排卵促進剤、ドーパミン作動薬、三環系抗うつ剤などがあります。これらは、女性では卵巣の排卵や卵胞の発育を促すことで効果を発揮し、一方、男性ではテストステロン値の回復や精子の質を向上させることで妊娠につなげます。近年、妊娠できないカップルの間で、不妊治療薬が注目されています。

不妊治療薬の市場動向:
不妊治療薬は、妊娠に貢献する個人の能力を回復させることで、カップルの妊娠の可能性を高めることを支援します。その結果、不妊症や流産が増加し、市場の成長を促進する主な要因となっています。このほか、利用可能な治療法に関する認識を広めるために各国政府が行ったいくつかの有利な取り組みが、不妊治療薬の需要を喚起しています。さらに、多忙な勤務体系やそれに伴うストレス、ライフスタイルの変化により、がん、肥満、糖尿病、甲状腺、多嚢胞性卵巣症候群(PCOS)、更年期障害などの慢性疾患の有病率が大幅に上昇しています。また、妊娠の遅れや晩婚化、アルコールや薬物の過剰摂取、喫煙などの不健康な生活習慣による出生率の低下が、製品の普及率を加速しています。さらに、複数の主要企業が研究開発活動に取り組み、より高い有効性、より少ない投与量、より少ない副作用を持つ革新的な不妊治療薬を発売しています。さらに、不妊治療薬開発のための公的資金の増加や、さまざまな規制機関からの迅速な医薬品承認が、市場の成長を後押ししています。その他、ジェネリック医薬品の需要の高まり、医療インフラの改善、消費者支出の増加、急速な都市化、技術の進歩なども、市場成長にプラスの影響を与えています。

主要な市場セグメンテーション
IMARC Groupは、不妊治療薬の世界市場レポートの各サブセグメントにおける主要動向の分析、および2023年から2028年までの世界、地域、国レベルでの予測を提供します。当レポートでは、薬剤クラス、投与経路、流通チャネル、エンドユーザーなどに基づいて市場を分類しています。

薬効分類別内訳:

ゴナドトロピン
アロマターゼ阻害剤
選択的エストロゲン受容体モジュレーター(SERMs)
ビグアナイド
その他

投与経路別構成比:

オーラル
静脈内投与
皮下
筋肉内

流通チャネル別構成比:

病院内薬局
小売薬局
その他

エンドユーザー別構成比:

男性
女性

地域別構成比:

北アメリカ
ユーエスエー
カナダ
アジア太平洋
中国
日本
インド
南朝鮮
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中近東・アフリカ

競争環境:
業界の競争環境は、主要企業のプロフィールとともに検討されています(Abbott Laboratories、Bayer AG、Ferring Pharmaceuticals、Livzon Pharmaceutical Group Inc.、Mankind Pharma、Merck & Co.Inc.、Merck KGaA、Novartis AG、Pfizer Inc.、Sanofi S.A.およびTheramexです。

本レポートで回答した主な質問
不妊治療薬の世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか?
COVID-19は世界の不妊治療薬市場にどのような影響を与えたか?
主要な地域市場とは?
薬効分類に基づく市場の内訳は?
投与経路に基づく市場の内訳は?
販売チャネルに基づく市場の内訳は?
エンドユーザー別の市場構成は?
業界のバリューチェーンにおける様々なステージは何か?
業界における主要な推進要因と課題は何か?
世界の不妊治療薬の市場構造と主要プレイヤーは?
業界における競争の度合いはどの程度か?

ページTOPに戻る


目次

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Infertility Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Drug Class
    6.1    Gonadotropin
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Aromatase Inhibitors
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Selective Estrogen Receptor Modulators (SERMs)
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Biguanides
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7   Market Breakup by Route of Administration
    7.1    Oral
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Intravenous
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Subcutaneous
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Intramuscular
        7.4.1 Market Trends
        7.4.2 Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Hospital Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by End User
    9.1    Male
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Female
        9.2.1 Market Trends
        9.2.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis
    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape
    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abbott Laboratories
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
        15.3.2    Bayer AG
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Ferring Pharmaceuticals
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
        15.3.4    Livzon Pharmaceutical Group Inc. 
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
        15.3.5    Mankind Pharma
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
        15.3.6    Merck & Co. Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    Merck KGaA
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    Novartis AG
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
        15.3.9    Pfizer Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
        15.3.10    Sanofi S.A.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Theramex
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio

List of Figures

Figure 1: Global: Infertility Drugs Market: Major Drivers and Challenges
Figure 2: Global: Infertility Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Infertility Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Infertility Drugs Market: Breakup by Drug Class (in %), 2022
Figure 5: Global: Infertility Drugs Market: Breakup by Route of Administration (in %), 2022
Figure 6: Global: Infertility Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Infertility Drugs Market: Breakup by End User (in %), 2022
Figure 8: Global: Infertility Drugs Market: Breakup by Region (in %), 2022
Figure 9: Global: Infertility Drugs (Gonadotropin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Infertility Drugs (Gonadotropin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Infertility Drugs (Aromatase Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Infertility Drugs (Aromatase Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Infertility Drugs (Biguanides) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Infertility Drugs (Biguanides) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Infertility Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Infertility Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Infertility Drugs (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Infertility Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Infertility Drugs (Intravenous) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Infertility Drugs (Intravenous) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Infertility Drugs (Subcutaneous) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Infertility Drugs (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Infertility Drugs (Intramuscular) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Infertility Drugs (Intramuscular) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Infertility Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Infertility Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Infertility Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Infertility Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Infertility Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Infertility Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Infertility Drugs (Male) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Infertility Drugs (Male) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Infertility Drugs (Female) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Infertility Drugs (Female) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: North America: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: North America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: United States: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: United States: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Canada: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Canada: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Asia-Pacific: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Asia-Pacific: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: China: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: China: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Japan: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Japan: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: India: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: India: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: South Korea: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: South Korea: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Australia: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Australia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Indonesia: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Indonesia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Others: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Europe: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Europe: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Germany: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Germany: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: France: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: France: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: United Kingdom: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: United Kingdom: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Italy: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Italy: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Spain: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Spain: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Russia: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Russia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Latin America: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Latin America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Brazil: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Brazil: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Mexico: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Mexico: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Others: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Middle East and Africa: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Middle East and Africa: Infertility Drugs Market: Breakup by Country (in %), 2022
Figure 85: Middle East and Africa: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Global: Infertility Drugs Industry: SWOT Analysis
Figure 87: Global: Infertility Drugs Industry: Value Chain Analysis
Figure 88: Global: Infertility Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Infertility Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Infertility Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
Table 3: Global: Infertility Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 4: Global: Infertility Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 5: Global: Infertility Drugs Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Infertility Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Infertility Drugs Market: Competitive Structure
Table 8: Global: Infertility Drugs Market: Key Players

 

ページTOPに戻る


 

Summary

The global infertility drugs market size reached US$ 3.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.24% during 2023-2028.

Infertility drugs refer to various medications used to treat infertility and enhance the reproductive health of an individual. They are either injected or taken orally. Some commonly used infertility drugs include gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), biguanides, ovulatory stimulants, dopamine agonists, and tricyclic antidepressants. They work by stimulating ovulation and follicle development of the ovary in women, whereas they help restore testosterone levels and improve the quality of sperm in men to bring about pregnancy. In recent years, infertility drugs have gained traction among couples who are unable to conceive.

Infertility Drugs Market Trends:
Infertility drugs assist in enhancing the chances of pregnancy in couples by restoring the ability of an individual to contribute to conception. As a result, the rising incidences of infertility and miscarriage represents the primary factor driving the market growth. Besides this, several favorable initiatives undertaken by governments of various countries to spread awareness regarding the available treatment options are catalyzing the demand for infertility drugs. Additionally, there has been a significant increase in the prevalence of chronic diseases, such as cancer, obesity, diabetes, thyroid, polycystic ovarian syndrome (PCOS), and menopausal disorders, on account of hectic work schedules, accompanying stress, and lifestyle changes. Along with this, the declining fertility rates due to delayed pregnancies, late marriages, and unhealthy habits, such as excessive consumption of alcohol, drugs, and smoking, are accelerating the product adoption rates. Furthermore, several key players are engaging in research and development (R&D) activities to launch innovative infertility drugs with enhanced efficacy, lower dosage requirements, and fewer side effects. Moreover, the increasing public funding for developing these drugs and faster drug approvals from various regulatory bodies are propelling the market growth. Other factors, including the escalating demand for generic medicines, improving healthcare infrastructure, rising consumer expenditure capacities, rapid urbanization, and technological advancements, are also providing a positive thrust to the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global infertility drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug class, route of administration, distribution channel and end user.

Breakup by Drug Class:

Gonadotropin
Aromatase Inhibitors
Selective Estrogen Receptor Modulators (SERMs)
Biguanides
Others

Breakup by Route of Administration:

Oral
Intravenous
Subcutaneous
Intramuscular

Breakup by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Others

Breakup by End User:

Male
Female

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.

Key Questions Answered in This Report:
How has the global infertility drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global infertility drugs market?
What are the key regional markets?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global infertility drugs market and who are the key players?
What is the degree of competition in the industry?



ページTOPに戻る


Table of Contents

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Infertility Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Drug Class
    6.1    Gonadotropin
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Aromatase Inhibitors
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Selective Estrogen Receptor Modulators (SERMs)
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Biguanides
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7   Market Breakup by Route of Administration
    7.1    Oral
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Intravenous
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Subcutaneous
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Intramuscular
        7.4.1 Market Trends
        7.4.2 Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Hospital Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by End User
    9.1    Male
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Female
        9.2.1 Market Trends
        9.2.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis
    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape
    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abbott Laboratories
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
        15.3.2    Bayer AG
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Ferring Pharmaceuticals
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
        15.3.4    Livzon Pharmaceutical Group Inc. 
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
        15.3.5    Mankind Pharma
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
        15.3.6    Merck & Co. Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    Merck KGaA
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    Novartis AG
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
        15.3.9    Pfizer Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
        15.3.10    Sanofi S.A.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Theramex
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio

List of Figures

Figure 1: Global: Infertility Drugs Market: Major Drivers and Challenges
Figure 2: Global: Infertility Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Infertility Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Infertility Drugs Market: Breakup by Drug Class (in %), 2022
Figure 5: Global: Infertility Drugs Market: Breakup by Route of Administration (in %), 2022
Figure 6: Global: Infertility Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Infertility Drugs Market: Breakup by End User (in %), 2022
Figure 8: Global: Infertility Drugs Market: Breakup by Region (in %), 2022
Figure 9: Global: Infertility Drugs (Gonadotropin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Infertility Drugs (Gonadotropin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Infertility Drugs (Aromatase Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Infertility Drugs (Aromatase Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Infertility Drugs (Biguanides) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Infertility Drugs (Biguanides) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Infertility Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Infertility Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Infertility Drugs (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Infertility Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Infertility Drugs (Intravenous) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Infertility Drugs (Intravenous) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Infertility Drugs (Subcutaneous) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Infertility Drugs (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Infertility Drugs (Intramuscular) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Infertility Drugs (Intramuscular) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Infertility Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Infertility Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Infertility Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Infertility Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Infertility Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Infertility Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Infertility Drugs (Male) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Infertility Drugs (Male) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Infertility Drugs (Female) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Infertility Drugs (Female) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: North America: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: North America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: United States: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: United States: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Canada: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Canada: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Asia-Pacific: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Asia-Pacific: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: China: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: China: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Japan: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Japan: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: India: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: India: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: South Korea: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: South Korea: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Australia: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Australia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Indonesia: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Indonesia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Others: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Europe: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Europe: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Germany: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Germany: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: France: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: France: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: United Kingdom: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: United Kingdom: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Italy: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Italy: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Spain: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Spain: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Russia: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Russia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Latin America: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Latin America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Brazil: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Brazil: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Mexico: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Mexico: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Others: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Middle East and Africa: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Middle East and Africa: Infertility Drugs Market: Breakup by Country (in %), 2022
Figure 85: Middle East and Africa: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Global: Infertility Drugs Industry: SWOT Analysis
Figure 87: Global: Infertility Drugs Industry: Value Chain Analysis
Figure 88: Global: Infertility Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Infertility Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Infertility Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
Table 3: Global: Infertility Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 4: Global: Infertility Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 5: Global: Infertility Drugs Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Infertility Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Infertility Drugs Market: Competitive Structure
Table 8: Global: Infertility Drugs Market: Key Players

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

IMARC Services Private Limited.社の医療分野での最新刊レポート

本レポートと同じKEY WORD(industry)の最新刊レポート


よくあるご質問


IMARC Services Private Limited.社はどのような調査会社ですか?


インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る